SARS-CoV-2, COVID-19 and the aging immune system

2021/09/14 by Juliet M. Bartleson, Dina Radenkovic, Dina Radenković +4 · 1 citation
Medicine · Neuroscience · #COVID-19 Clinical Research Studies #Long-Term Effects of COVID-19 #Tryptophan and brain disorders

paper · pdf · doi:10.1038/s43587-021-00114-7

crossref issued 2021/09/14 · crossref published 2021/09/14 · crossref published-online 2021/09/14 · openalex publication_date 2021/09/14 · crossref created 2021/09/14 · openalex created_date 2021/09/27 · crossref deposited 2023/11/08 · openalex updated_date 2026/08/04 · crossref indexed 2026/08/04

Citations

• The nuclear factor- B-interleukin-6 signalling pathway mediating vascular inflammation
• Increased cytokine production in mononuclear cells of healthy elderly people
• Age-Related Decrease in TCR Repertoire Diversity Measured with Deep and Normalized Sequence Profiling
• Aging and the immune system: An overview
• Chronic inflammation in the etiology of disease across the life span
• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
• Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
• Age-Associated B Cells
• A pneumonia outbreak associated with a new coronavirus of probable bat origin
• Pathological findings of COVID-19 associated with acute respiratory distress syndrome
• Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
• Clinical Characteristics of Coronavirus Disease 2019 in China
• Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
• Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
• Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
• Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
• Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
• Incidence of thrombotic complications in critically ill ICU patients with COVID-19
• The trinity of COVID-19: immunity, inflammation and intervention
• Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
• Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
• Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
• Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
• Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
• Autoantibodies against type I IFNs in patients with life-threatening COVID-19
• Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
• Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Cited by

• Interferon [wikipedia]